Skip to content

NEW INSTRUPHAR: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

NEW INSTRUPHAR

BE 0444.180.618
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€34,248
2024 · -€21,628-€12,620
Equity
€445,065
2024 · €509,313-€64,248
Cash
€65,787
2024 · €76,888-€11,101
Balance sheet total
€599,845
2024 · €677,346-€77,501

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€52,936

    down €52,936 (-10.9%), from €485,510 to €432,574

    of which Plant, machinery and equipment: -€26,780

  • Receivables within one year -€16,681

    down €16,681 (-42.7%), from €39,036 to €22,355

    of which Other amounts receivable: -€10,142

  • Cash -€11,101

    down €11,101 (-14.4%), from €76,888 to €65,787

    mainly Net result for the year (-€34,248) and Contributions, distributions and other (-€30,000)

Equity and liabilities
  • Reserves -€64,248

    down €64,248 (-14.2%), from €453,313 to €389,065

    of which Tax-exempt reserves: -€36,363

  • Debts after one year -€18,312

    down €18,312 (-34.7%), from €52,726 to €34,414

  • Other debts +€11,407

    new in 2025: €11,407

  • Provisions -€9,319

    down €9,319 (-18.4%), from €50,582 to €41,263

Income statement
  • Gross operating margin -€16,026

    down €16,026 (-15.2%), from €105,648 to €89,622

  • Taxes -€5,998

    down €5,998 (-75.6%), from €7,934 to €1,936

  • Staff costs +€4,661

    up €4,661 (+7.3%), from €64,015 to €68,676

  • Depreciation -€2,370

    down €2,370 (-4.3%), from €55,306 to €52,936

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€21,628
Gross operating margin -€16,026
Staff costs -€4,661
Depreciation +€2,370
Other operating charges +€96
Financial charges +€14
Taxes +€5,998
Deferred taxes and other -€412
Result 2025 -€34,248
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€36,893
Investment €0
Financing -€47,995
Cash 2024 €76,888
Net result for the year -€34,248
Depreciation +€52,936
Stocks and contracts -€1,242
Receivables within one year +€16,681
Deferred charges and accrued income -€1,976
Provisions -€9,319
Trade debts +€4,839
Tax, wage and social debts -€2,185
Other debts +€11,407
Debts after one year -€18,312
Current portion of long-term debt +€317
Contributions, distributions and other -€30,000
Cash 2025 €65,787
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €677,346 €599,845 -€77,501 -11.4%
Fixed assets 21/28 €485,510 €432,574 -€52,936 -10.9%
Tangible fixed assets 22/27 €485,510 €432,574 -€52,936 -10.9%
Land and buildings 22 €450,413 €424,257 -€26,156 -5.8%
Plant, machinery and equipment 23 €35,097 €8,317 -€26,780 -76.3%
Current assets 29/58 €191,836 €167,271 -€24,565 -12.8%
Stocks and contracts in progress 3 €75,911 €77,153 +€1,242 +1.6%
Stocks 30/36 €75,911 €77,153 +€1,242 +1.6%
Amounts receivable within one year 40/41 €39,036 €22,355 -€16,681 -42.7%
Trade receivables 40 €28,894 €22,355 -€6,539 -22.6%
Other amounts receivable 41 €10,142 - -€10,142
Cash at bank and in hand 54/58 €76,888 €65,787 -€11,101 -14.4%
Deferred charges and accrued income 490/1 - €1,976 +€1,976
Total equity and liabilities 10/49 €677,346 €599,845 -€77,501 -11.4%
Equity 10/15 €509,313 €445,065 -€64,248 -12.6%
Contributions 10/11 €56,000 €56,000 = 0.0%
Reserves 13 €453,313 €389,065 -€64,248 -14.2%
Tax-exempt reserves 132 €197,371 €161,007 -€36,363 -18.4%
Distributable reserves 133 €255,942 €228,057 -€27,885 -10.9%
Provisions and deferred taxes 16 €50,582 €41,263 -€9,319 -18.4%
Deferred taxes 168 €50,582 €41,263 -€9,319 -18.4%
Amounts payable 17/49 €117,450 €113,517 -€3,933 -3.3%
Amounts payable after more than one year 17 €52,726 €34,414 -€18,312 -34.7%
Financial debts 170/4 €52,726 €34,414 -€18,312 -34.7%
Amounts payable within one year 42/48 €63,113 €77,491 +€14,378 +22.8%
Current portion of amounts payable after more than one year 42 €17,995 €18,312 +€317 +1.8%
Trade debts 44 €10,227 €15,065 +€4,839 +47.3%
Suppliers 440/4 €10,227 €15,065 +€4,839 +47.3%
Taxes, remuneration and social security 45 €34,892 €32,707 -€2,185 -6.3%
Taxes 450/3 €23,330 €19,074 -€4,256 -18.2%
Remuneration and social security 454/9 €11,562 €13,633 +€2,071 +17.9%
Other amounts payable 47/48 - €11,407 +€11,407
Accrued charges and deferred income 492/3 €1,611 €1,611 = 0.0%
Remuneration, social security and pensions 62 €64,015 €68,676 +€4,661 +7.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €55,306 €52,936 -€2,370 -4.3%
Other operating charges 640/8 €8,029 €7,933 -€96 -1.2%
Gross operating margin 9900 €105,648 €89,622 -€16,026 -15.2%
Operating profit (loss) 9901 -€21,701 -€39,922 -€18,221 -84.0%
Financial charges 65/66B €1,724 €1,710 -€14 -0.8%
Recurring financial charges 65 €1,724 €1,710 -€14 -0.8%
Profit (loss) for the period before taxes 9903 -€23,425 -€41,631 -€18,207 -77.7%
Transfer from deferred taxes 780 €9,731 €9,319 -€412 -4.2%
Income taxes 67/77 €7,934 €1,936 -€5,998 -75.6%
Profit (loss) for the period 9904 -€21,628 -€34,248 -€12,620 -58.4%
Transfer from tax-exempt reserves 789 €37,970 €36,363 -€1,607 -4.2%
Profit (loss) for the period to be appropriated 9905 €16,342 €2,115 -€14,227 -87.1%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.